MegaMD Co. Ltd Net Assets
MegaMD Co. Ltd net assets. Based on the latest financial reports, MegaMD Co. Ltd (133750) has net assets worth ₩66.39 Billion KRW (≈ $44.99 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩83.25 Billion ≈ $56.42 Million USD) and total liabilities (₩16.86 Billion ≈ $11.43 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset growth rate of MegaMD Co. Ltd to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩66.39 Billion |
| % of Total Assets | 79.74% |
| Annual Growth Rate | 4.41% |
| 5-Year Change | -0.31% |
| 10-Year Change | 5.3% |
| Growth Volatility | 14.1 |
Net Assets of MegaMD Co. Ltd (2014–2025)
Net assets of MegaMD Co. Ltd from 2014 to 2025. This chart illustrates how MegaMD Co. Ltd's net assets have evolved over time, based on quarterly financial data. See how leveraged is MegaMD Co. Ltd's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for MegaMD Co. Ltd (2014–2025)
The table below shows the annual net assets of MegaMD Co. Ltd from 2014 to 2025. For live market cap and overall valuation, see 133750 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩66.39 Billion ≈ $44.99 Million |
+0.93% |
| 2024-12-31 | ₩65.78 Billion ≈ $44.58 Million |
+5.68% |
| 2023-12-31 | ₩62.24 Billion ≈ $42.18 Million |
-5.32% |
| 2022-12-31 | ₩65.74 Billion ≈ $44.55 Million |
-1.28% |
| 2021-12-31 | ₩66.60 Billion ≈ $45.13 Million |
+7.58% |
| 2020-12-31 | ₩61.90 Billion ≈ $41.95 Million |
+7.92% |
| 2019-12-31 | ₩57.36 Billion ≈ $38.87 Million |
-1.19% |
| 2018-12-31 | ₩58.05 Billion ≈ $39.34 Million |
-0.04% |
| 2017-12-31 | ₩58.08 Billion ≈ $39.36 Million |
-7.89% |
| 2016-12-31 | ₩63.05 Billion ≈ $42.73 Million |
+3.69% |
| 2015-12-31 | ₩60.80 Billion ≈ $41.21 Million |
+47.16% |
| 2014-12-31 | ₩41.32 Billion ≈ $28.00 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to MegaMD Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 52.4% over the analyzed period, indicating profitable operations and earnings retention.
MegaMD Co. Ltd Net Assets Breakdown (December 2025)
MegaMD Co. Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩42.81 Billion | 64.49% |
| Other Components | ₩23.58 Billion | 35.51% |
| Total Equity | ₩66.39 Billion | 100.00% |
MegaMD Co. Ltd Competitors by Market Cap
The table below lists competitors of MegaMD Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Allied Industrial Ltd
TWO:4702
|
$20.65 Million |
|
Sidiz Inc
KO:134790
|
$20.65 Million |
|
Korean Drug Co. Ltd
KQ:014570
|
$20.65 Million |
|
9F Inc
NASDAQ:JFU
|
$20.66 Million |
|
Rex Industry Bhd
KLSE:9946
|
$20.64 Million |
|
Pure Hydrogen Corporation Ltd
AU:PH2
|
$20.63 Million |
|
Sun-Sea Construction
TWO:5516
|
$20.62 Million |
|
S&K Polytec Co. Ltd
KQ:091340
|
$20.62 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MegaMD Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 65,778,680,170 to 66,389,264,980, a change of 610,584,810 (0.9%).
- Net income of 2,789,882,410 contributed positively to equity growth.
- Dividend payments of 1,324,493,100 reduced retained earnings.
- Other factors decreased equity by 854,804,500.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩2.79 Billion | +4.2% |
| Dividends Paid | ₩1.32 Billion | -2.0% |
| Other Changes | ₩-854.80 Million | -1.29% |
| Total Change | ₩- | 0.93% |
Book Value vs Market Value Analysis
This analysis compares MegaMD Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.46x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩2997.12 | ₩1380.00 | x |
| 2017-12-31 | ₩2760.70 | ₩1380.00 | x |
| 2018-12-31 | ₩2759.56 | ₩1380.00 | x |
| 2019-12-31 | ₩2635.38 | ₩1380.00 | x |
| 2020-12-31 | ₩2804.29 | ₩1380.00 | x |
| 2021-12-31 | ₩3016.77 | ₩1380.00 | x |
| 2022-12-31 | ₩2978.11 | ₩1380.00 | x |
| 2023-12-31 | ₩2819.67 | ₩1380.00 | x |
| 2024-12-31 | ₩2979.78 | ₩1380.00 | x |
| 2025-12-31 | ₩3007.44 | ₩1380.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MegaMD Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.20%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.07%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 1.25x
- Recent ROE (4.20%) is below the historical average (4.34%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 11.04% | 6.86% | 1.05x | 1.53x | ₩418.79 Million |
| 2015 | 14.40% | 13.08% | 0.75x | 1.47x | ₩2.68 Billion |
| 2016 | 2.98% | 3.12% | 0.65x | 1.46x | ₩-4.43 Billion |
| 2017 | -4.85% | -4.07% | 0.75x | 1.59x | ₩-8.62 Billion |
| 2018 | 1.91% | 1.47% | 0.75x | 1.73x | ₩-4.70 Billion |
| 2019 | 0.72% | 0.51% | 0.74x | 1.89x | ₩-5.32 Billion |
| 2020 | 7.91% | 5.94% | 0.73x | 1.83x | ₩-1.29 Billion |
| 2021 | 9.99% | 8.37% | 0.69x | 1.72x | ₩-9.22 Million |
| 2022 | 3.21% | 3.28% | 0.69x | 1.42x | ₩-4.46 Billion |
| 2023 | -5.14% | -8.87% | 0.43x | 1.36x | ₩-9.42 Billion |
| 2024 | 5.75% | 10.37% | 0.42x | 1.33x | ₩-2.79 Billion |
| 2025 | 4.20% | 8.07% | 0.42x | 1.25x | ₩-3.85 Billion |
Industry Comparison
This section compares MegaMD Co. Ltd's net assets metrics with peer companies in the Education & Training Services industry.
Industry Context
- Industry: Education & Training Services
- Average net assets among peers: $246,766,740,852
- Average return on equity (ROE) among peers: 2.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MegaMD Co. Ltd (133750) | ₩66.39 Billion | 11.04% | 0.25x | $20.64 Million |
| Daekyo (019680) | $313.25 Billion | 0.21% | 0.93x | $71.79 Million |
| Daekyo Co Ltd (019685) | $516.40 Billion | -8.45% | 0.58x | $9.03 Million |
| JLS Co.Ltd (040420) | $63.97 Billion | 12.00% | 0.73x | $58.11 Million |
| Digital Daesung Co. Ltd (068930) | $168.73 Billion | 7.42% | 0.47x | $167.10 Million |
| MegaStudyEdu Co. Ltd (215200) | $171.48 Billion | 1.84% | 0.35x | $270.48 Million |
About MegaMD Co. Ltd
MegaMD Co., Ltd. engages in the operation of educational institutions in South Korea. The company's education services specialize in infant, elementary, middle, and high school education, as well as adult entrance exams. It is also involved in the operation of online lecture sites; and provision of information services. The company was founded in 2004 and is headquartered in Seoul, South Korea.